USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
Key Challenges, Trends, and Changes Transforming the Life Sciences Industry
19-Feb-2025
Global
Market Research
PFTF-01-00-00-00
HC_2025_1314
$2,450.00
Special Price $2,205.00 save 10 %
Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers.
This analysis explores the strategic imperatives shaping and transforming the life sciences industry. They are as follows:
SaaS evolution provides adaptive intelligence for laboratories
CDMOs augment competencies in new modalities, and digital transformation delivers end-to-end partnerships
Expanding direct-to-consumer (DTC) genetic testing beyond ancestry testing to multi-pathogenic STIs
Uncertainty about trade wars disrupts pharmaceutical supply chains
Decentralized clinical trials (DCTs) boost efficiency for CGTs and rare disorders
Next-generation sequencing (NGS) and liquid biopsy revolutionize oncology diagnostics
Failed clinical trials and shifting market conditions setback biotech innovation
ESG initiatives climb to the top of CEOs' strategic priorities
Real-world insight (RWI) emerges as a strategic compass point to reimagine commercial strategies
CRISPR technology advances biologics R&D
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
Top Transformations Impacting the Growth of the Life Sciences Industry
Key Industry Trends and Challenges
Transformation 1: SaaS Evolution Provides Adaptive Intelligence for Laboratories
Transformation 1: SaaS Evolution Provides Adaptive Intelligence for Laboratories (continued)
Transformation 2: CDMOs Augment Competencies in New Modalities, and Digital Transformation Delivers End-to-End Partnerships
Transformation 2: CDMOs Augment Competencies in New Modalities, and Digital Transformation Delivers End-to-End Partnerships (continued)
Transformation 3: Expanding Direct-to-Consumer (DTC) Genetic Testing Beyond Ancestry Testing to Multi-pathogenic STIs
Transformation 3: Expanding DTC Genetic Testing Beyond Ancestry Testing to Multi-pathogenic STIs (continued)
Transformation 4: Uncertainty About Trade Wars Disrupts Pharmaceutical Supply Chains
Transformation 4: Uncertainty About Trade Wars Disrupts Pharmaceutical Supply Chains (continued)
Transformation 5: Decentralized Clinical Trials (DCTs) Boosting Efficiency for CGTs and Rare Disorders
Transformation 5: DCTs Boosting Efficiency for CGTs and Rare Disorders (continued)
Transformation 6: Next-generation Sequencing (NGS) and Liquid Biopsy Revolutionize Oncology Diagnostics
Transformation 6: NGS and Liquid Biopsy Revolutionize Oncology Diagnostics (continued)
Transformation 7: Failed Clinical Trials and Shifting Market Conditions Setback Biotech Innovation
Transformation 7: Failed Clinical Trials and Shifting Market Conditions Setback Biotech Innovation (continued)
Transformation 8: ESG Initiatives Climb to the Top of CEOs' Strategic Priorities
Transformation 8: ESG Initiatives Climb to the Top of CEOs' Strategic Priorities (continued)
Transformation 9: Real-world Insight (RWI) Emerges as a Strategic Compass Point to Reimagine Commercial Strategies
Transformation 9: RWI Emerges as a Strategic Compass Point to Reimagine Commercial Strategies (continued)
Transformation 10: CRISPR Technology Advances Biologics R&D
Transformation 10: CRISPR Technology Advances Biologics R&D (continued)
Frost & Sullivan Analytics Perspectives
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Pharmaceuticals research
31 Jul 2026 | Global | Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...
30 Jul 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...
17 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...
13 Jul 2026 | Global | Technology Research
RNA Therapies in Rare Diseases
Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emergi...
08 Jul 2026 | Global | Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Chandni Hussain |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Life sciences market trends |
| Keyword 2 | Precision medicine growth |
| Keyword 3 | Life sciences regulations |
| Podcast | No |
| WIP Number | PFTF-01-00-00-00 |